FSD Pharma Inc Class B is a drug manufacturers - specialty & generic business based in the US. FSD Pharma Inc Class B shares (HUGE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.39 – an increase of 15.42% over the previous week.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $5.39 |
|---|---|
| 52-week range | $3.50 - $97.50 |
| 50-day moving average | $8.13 |
| 200-day moving average | $36.69 |
| Wall St. target price | $2.60 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-16.25 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.8 from 2024-10-15
| 1 week (2024-10-10) | 2.78% |
|---|---|
| 1 month (2024-09-17) | 14.29% |
| 3 months (2024-07-17) | 3,059.97% |
| 6 months (2024-04-17) | 941.21% |
| 1 year (2023-10-17) | 306.78% |
|---|---|
| 2 years (2022-10-17) | 503.77% |
| 3 years (2021-10-15) | 235.66% |
| 5 years (2019-10-17) | 5.2 |
| Gross profit TTM | $-3,331,945 |
|---|---|
| Return on assets TTM | -36.47% |
| Return on equity TTM | -63.89% |
| Profit margin | 0% |
| Book value | $17.09 |
| Market Capitalization | $66,671 |
TTM: trailing 12 months
We're not expecting FSD Pharma Inc Class B to pay a dividend over the next 12 months.
FSD Pharma Inc Class B's shares were split on a 1:65 basis on 14 August 2024. So if you had owned 65 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FSD Pharma Inc Class B shares – just the quantity. However, indirectly, the new 6400% higher share price could have impacted the market appetite for FSD Pharma Inc Class B shares which in turn could have impacted FSD Pharma Inc Class B's share price.
Over the last 12 months, FSD Pharma Inc Class B's shares have ranged in value from as little as $3.5 up to $97.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FSD Pharma Inc Class B's is 0.848. This would suggest that FSD Pharma Inc Class B's shares are less volatile than average (for this exchange).
FSD Pharma Inc. , a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.